Pharma Deals Review, Vol 2005, No 63 (2005)

Font Size:  Small  Medium  Large

Purdue Pharma to Market Labopharm’s Once-Daily Tramadol in the US

Business Review Editor

Abstract


Purdue Pharma has acquired the US rights to market, sell and distribute Labopharm’s Tramadol, once-daily analgesic drug. Labopharm will receive up to US$170 M from Purdue Pharma.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.